OSN PremiumOSP InsiderRegulatorySpine

icotec AG Granted FDA Clearance To Market VADER®one Pedicle Screw System

ALTSTAETTEN, Switzerland, July 8, 2019 /PRNewswire/ — icotec AG, a Swiss company, today announced the VADER®one pedicle screw system was granted U.S. Food and Drug Administration (FDA) 510(k) clearance for both minimally-invasive and open spine surgical procedures. VADER®one, made from icotec’s unique BlackArmor® material, was designed for secure stabilization and post-operative visualization, which is important after spinal tumor procedures.

Lateral x-ray image of a patient stabilized with icotec VADER® pedicle screw system (courtesy of Prof. B. Meyer, TU Munich, Germany)

In a recent publication, the neurosurgery and radiation oncology group from Technical University of Munich, Germany, stated: “In terms of postoperative evaluation of residual or recurrent tumor within the periphery of the spinal canal and column and for accurate radiation planning, CFRP* implants hold major advantages when compared with standard titanium implants by generating significantly fewer image artifacts.” [1]

VADER®one is made from icotec’s unique BlackArmor® Carbon/PEEK material, which consists of continuous carbon fibers combined with PEEK (polyetheretherketone), and is produced using icotec’s injection molding CFM (Composite Flow Molding) manufacturing technology. This process allows for 3-dimensionally reinforced, nonmetallic implants providing both, the strength and radiolucency needed for oncology patients and their treatment.

icotec is the only company manufacturing spinal implants made of radiolucent BlackArmor® Carbon/PEEK composite material. Implants made of BlackArmor® are biocompatible and have been successfully implanted for over 15 years. Their X-ray, CT and MRI translucency makes a significant difference during the surgical procedure, and postoperatively in assessing the site of care. In patients with spinal tumors, optimal delineation of the tumor from healthy tissue can facilitate radiotherapy planning, improve radiosurgery treatment and allow immediate and precise monitoring of possible relapses (tumor recurrence).

“Our ability to use icotec’s BlackArmor® material for stabilizing the spine offers advanced-stage tumor patients the ability to consider a larger variety of treatment options with improved therapy planning, dose delivery and follow-up evaluation,” says Roger Stadler, CEO of icotec AG, Switzerland. “It is a great achievement for our company and our employees to obtain FDA clearance, a significant milestone in our company’s history.”

The VADER®one implants are intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the thoracic and lumbar spine in whom life expectancy is of insufficient duration to permit achievement of fusion.



icotec AG is a family-owned SME in Altstaetten, Switzerland established in 1999. icotec designs and manufactures nonmetallic spinal implants made from BlackArmor® (Carbon/PEEK). More than 10’000 icotec BlackArmor® pedicle screws have been implanted in countries outside the USA since their market introduction.

For more information, visit our website www.icotec-medical.com or contact us at media@icotec-medical.com

* CFRP (carbon fiber-reinforced polyetheretherketone) is identical to Carbon/PEEK.

[1] Ringel, F., et al., Radiolucent carbon-fiber reinforced pedicle screws for the treatment of spinal tumors: Advantages for radiation planning and follow-up imaging. World Neurosurg, 2017.

SOURCE Icotec Medical

[mepr-show if=”rule: 52327″ unauth=”both”]

According to The American Cancer Society, approximately 23,820 malignant tumors of the brain or spinal cord (13,410 in males and 10,410 in females) will be diagnosed in 2019. These numbers would be much higher if benign (non-cancerous) tumors were included. Outside of the US, carbon fiber-based screws have been used for years. Carbo-Fix was the first to receive US approval in July of 2018—now icotec has its own version.
These new systems are very costly but provide great benefits to patients. They help reduce common scattering issues we see with titanium screws. According to icotec, radiolucent carbon/PEEK material enables a more homogenous planning of the radiation dose. If these products can provide better outcomes for these types of patients, then I welcome them. Hopefully, competition in the market will provide better value over time.

Mike Adams, sr vp of commercialization

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button